GYRE R&D Expense Growth
Gyre Therapeutics Inc · R&D Expense Growth
GYRE R&D Expense Growth
Latest reported13.92%period ending
GYRE FY R&D Growth (YoY) (0.00% → 13.92%)
Latest values, visible window
High-resolution chart · PNG
GYRE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 13.9222% | |
| -12.7431% | |
| -17.4158% | |
| -74.1599% | |
| 21.8952% | |
| 20.7848% | |
| 104.2423% | |
| 67.1519% | |
| 11.1813% | |
| 93.9409% | |
| 13.1194% | |
| -86.4392% | |
| -20.8752% | |
| -48.4461% | |
| 47.515% | |
| 60.6461% | |
| -1.957% | |
| 18.3755% | |
| 58.8934% | |
| -10.1585% | |
| 6.5021% | |
| 25.2593% | |
| 11.9121% | |
| 99.264% | |
| 0% |